Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660

Article  CAS  PubMed  Google Scholar 

Kulik L, El-Serag HB (2019) Epidemiology and management of hepatocellular carcinoma. Gastroenterology 156:477–491. e1

Article  PubMed  Google Scholar 

Rumgay H, Arnold M, Ferlay J et al (2022) Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol 77:1598–1606. https://doi.org/10.1016/j.jhep.2022.08.021

Article  PubMed  PubMed Central  Google Scholar 

Qin S, Li A, Yi M et al (2019) Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy. J Hematol Oncol 12:27. https://doi.org/10.1186/s13045-019-0718-5

Article  PubMed  PubMed Central  Google Scholar 

Saraon P, Pathmanathan S, Snider J et al (2021) Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches. Oncogene 40:4079–4093. https://doi.org/10.1038/s41388-021-01841-2

Article  CAS  PubMed  Google Scholar 

Alexandrescu DT, McClure R, Farzanmehr H, Dasanu CA (2008) Secondary erythrocytosis produced by the tyrosine kinase inhibitors sunitinib and sorafenib. J Clin Oncol 26:4047–4048. https://doi.org/10.1200/JCO.2008.18.3525

Legros L, Pascale A, Guettier C et al (2023) Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma. Cancer Chemother Pharmacol 91:337–344. https://doi.org/10.1007/s00280-023-04519-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alexandre I, Billemont B, Meric JB et al (2009) Axitinib induces paradoxical erythropoietin synthesis in metastatic renal cell carcinoma. J Clin Oncol 27:472–473; author reply 473–474. https://doi.org/10.1200/JCO.2008.20.1087

Tripathi A, Jacobus S, Feldman H et al (2017) Prognostic significance of increases in hemoglobin in renal cell carcinoma patients during treatment with VEGF-directed therapy. Clin Genitourin Cancer 15:396–402. https://doi.org/10.1016/j.clgc.2016.12.009

Article  PubMed  Google Scholar 

Harshman LC, Kuo CJ, Wong BY et al (2009) Increased hemoglobin associated with VEGF inhibitors in advanced renal cell carcinoma. Cancer Invest 27:851–856. https://doi.org/10.1080/07357900902744528

Article  CAS  PubMed  Google Scholar 

Kaur J, Tuler S, Dasanu CA (2022) Sustained erythrocytosis due to the use of lenvatinib. J Oncol Pharm Pract 28:475–478. https://doi.org/10.1177/10781552211039108

Article  PubMed  Google Scholar 

Zhao J, Du F, Zhang Y et al (2017) Impact of high altitude on clinicopathological features and prognosis after R0 resection for gastric cancer: A Population-Based multicenter study. J Environ Pathol Toxicol Oncol 36:1–14. https://doi.org/10.1615/JEnvironPatholToxicolOncol.2016016904

Article  PubMed  Google Scholar 

Vélez-Páez JL, Baldeón-Rojas L, Cañadas Herrera C et al (2023) Receiver operating characteristic (ROC) to determine cut-off points of clinical and biomolecular markers to discriminate mortality in severe COVID-19 living at high altitude. BMC Pulm Med 23:393. https://doi.org/10.1186/s12890-023-02691-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang H-X, Li Y-D, Liang J et al (2024) Altitude-related features and prognosis in patients with reversible splenial lesion syndrome. Ann Med 56:2401107. https://doi.org/10.1080/07853890.2024.2401107

Article  PubMed  PubMed Central  Google Scholar 

Liu H, Wang X, Wang L et al (2024) Mortality burden of liver Cancer in china: an observational study from 2008 to 2020. J Clin Transl Hepatol 12:371–380. https://doi.org/10.14218/JCTH.2023.00455

Article  PubMed  PubMed Central  Google Scholar 

Beall CM (2007) Two routes to functional adaptation: Tibetan and Andean high-altitude natives. Proc Natl Acad Sci U S A 104:8655–8660. https://doi.org/10.1073/pnas.0701985104

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bigham AW, Wilson MJ, Julian CG et al (2013) Andean and Tibetan patterns of adaptation to high altitude. Am J Hum Biol 25:190–197. https://doi.org/10.1002/ajhb.22358

Article  PubMed  Google Scholar 

Peng P, Yang Y, Zhang Z, et al H et al (2011) Genetic variations in Tibetan populations and high-altitude adaptation at the Himalayas. Mol Biol Evol 28:1075–1081. https://doi.org/10.1080/07357900902744528

Article  CAS  PubMed  Google Scholar 

Xu S, Li S, Yang Y et al (2011) A genome-wide search for signals of high-altitude adaptation in Tibetans. Mol Biol Evol 28:1003–1011. https://doi.org/10.1093/molbev/msq277

Beall CM, Cavalleri GL, Deng L et al (2010) Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan Highlanders. Proc Natl Acad Sci U S A 107:11459–11464. https://doi.org/10.1073/pnas.100244310

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beall CM, Brittenham GM, Strohl KP et al (1998) Hemoglobin concentration of high-altitude Tibetans and Bolivian Aymara. Am J Phys Anthropol 106:385–400. https://doi.org/10.1002/(SICI)1096-8644(199807)106:3%3C385::AID-AJPA10%3E3.0.CO;2-X

Article  CAS  PubMed  Google Scholar 

von Elm E, Altman DG, Egger M et al (2007) Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806–808. https://doi.org/10.1136/bmj.39335.541782.AD

Article  Google Scholar 

Vaupel P, Mayer A (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26:225–239. https://doi.org/10.1007/s10555-007-9055-1

Article  CAS  PubMed  Google Scholar 

Karakashev SV, Reginato MJ (2015) Progress toward overcoming hypoxia-induced resistance to solid tumor therapy. Cancer Manag Res 7:253–264. https://doi.org/10.2147/CMAR.S58285

Wang Q, Liu J, Hu S et al (2025) Establishment of reference intervals for complete blood count in healthy adults at different altitudes on the Western Sichuan plateau. Front Med 12. https://doi.org/10.3389/fmed.2025.1586778

Gassmann M, Mairbäurl H, Livshits L et al (2019) The increase in hemoglobin concentration with altitude varies among human populations. Ann N Y Acad Sci 1450:204–220. https://doi.org/10.1111/nyas.14136

Article  CAS  PubMed  Google Scholar 

Tapio J, Vähänikkilä H, Kesäniemi YA et al (2021) Higher hemoglobin levels are an independent risk factor for adverse metabolism and higher mortality in a 20-year follow-up. Sci Rep 11:19936. https://doi.org/10.1038/s41598-021-99217-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tam BYY, Wei K, Rudge JS et al (2006) VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis. Nat Med 12:793–800. https://doi.org/10.1038/nm1428

Article  CAS  PubMed  Google Scholar 

van der Veldt AAM, Boven E, Vroling L et al (2009) Sunitinib-induced hemoglobin changes are related to the dosing schedule. J Clin Oncol 27:1339–1340; author reply 1340–1342. https://doi.org/10.1200/JCO.2008.20.6151

Cai W, Liu S, Liu Z et al (2020) Downregulation of lung miR-203a-3p expression by high-altitude hypoxia enhances vegf/notch signaling. Aging 12:4247–4267. https://doi.org/10.18632/aging.102878

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang K, Zhang Z, Li Y et al (2020) Expression and distribution of HIF-1α, HIF-2α, VEGF, VEGFR-2 and HIMF in the kidneys of Tibetan sheep, plain sheep and goat. Folia Morphol 79:748–755. https://doi.org/10.5603/FM.a2020.0011

Article  CAS  Google Scholar 

Ma L, Chen Y, Jin G et al (2015) Vascular Endothelial Growth Factor as a Prognostic Parameter in Subjects with Plateau Red Face. High Alt Med Biol 16:147–153. https://doi.org/10.1089/ham.2014.1091

Zhu J, Duan Y, Duo D et al (2022) High-altitude hypoxia influences the activities of the Drug-Metabolizing enzyme CYP3A1 and the pharmacokinetics of four cardiovascular system drugs. Pharmaceuticals (Basel) 15:1303. https://doi.org/10.3390/ph15101303

Article  CAS  PubMed  Google Scholar 

Vavrová K, Indra R, Pompach P et al (2022) The impact of individual human cytochrome P450 enzymes on oxidative metabolism of anticancer drug lenvatinib. Biomed Pharmacother 145:112391. https://doi.org/10.1016/j.biopha.2021.112391